Nutra Pharma Corp financial data

Industry
Medicinal Chemicals & Botanical Products
Location
12538 W. Atlantic Blvd., Coral Springs, FL
State of incorporation
CA
Fiscal year end
December 31
Former names
CYBER VITAMIN COM (to 2/28/2002)
Latest financial report
10-Q - Q3 2022 - Nov 21, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.84 % +181%
Quick Ratio 0.27 % +302%
Debt-to-equity -104 % -2.48%
Return On Equity -41.3 % -170%
Return On Assets 942 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.6B shares
Common Stock, Shares, Outstanding 7.6B shares +3.95%
Common Stock, Value, Issued 7.6M USD +3.95%
Weighted Average Number of Shares Outstanding, Basic 7.59B shares +4.16%
Weighted Average Number of Shares Outstanding, Diluted 15.6B shares +23.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 163K USD +87.8%
Operating Income (Loss) -1.38M USD +25.2%
Nonoperating Income (Expense) 8.45M USD -94.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.07M USD -96.3%
Net Income (Loss) Attributable to Parent 7.07M USD -96.3%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 21.6K USD -47.9%
Inventory, Net 49.3K USD +49.5%
Assets, Current 462K USD -19.2%
Property, Plant and Equipment, Net 85.6K USD +97.6%
Operating Lease, Right-of-Use Asset 43.4K USD -61.3%
Assets 691K USD -17.3%
Accounts Payable, Current 713K USD +16.5%
Accrued Liabilities, Current 964K USD +18.3%
Contract with Customer, Liability, Current 111K USD
Liabilities, Current 16.1M USD -32.1%
Liabilities 16.3M USD -33.3%
Retained Earnings (Accumulated Deficit) -76.8M USD +8.48%
Stockholders' Equity Attributable to Parent -15.6M USD +33.9%
Liabilities and Equity 691K USD -17.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -258K USD +56.6%
Net Cash Provided by (Used in) Financing Activities 236K USD -62.8%
Net Cash Provided by (Used in) Investing Activities -62K USD -61.2%
Common Stock, Shares Authorized 12B shares +50%
Common Stock, Shares, Issued 7.6B shares +3.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -84K USD -4898%
Interest Paid, Excluding Capitalized Interest, Operating Activities 25.6K USD -14.7%
Operating Lease, Liability 20K USD -79.1%
Depreciation 20K USD +167%
Payments to Acquire Property, Plant, and Equipment 58K USD +483%
Lessee, Operating Lease, Liability, to be Paid 20.3K USD -79.9%
Property, Plant and Equipment, Gross 325K USD +23.7%
Operating Lease, Liability, Current 20K USD -73.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 267 USD -94.9%